Civic Intelligence

The Foundation for Embryonic Competence Inc.

990 • Fiscal year 2014 • EIN 46-3032063

Oct 01, 2013 to Sep 30, 2014

Basking Ridge, NJ
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

9th percentile

0.01x

Higher debt load relative to assets than 9% of similar nonprofits.

2014 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2014

Liabilities / Revenue

5th percentile

0.01x

Higher debt load relative to revenue than 5% of similar nonprofits.

2014 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2014

Net Margin

99th percentile

96%

Higher net margin than 99% of similar nonprofits.

2014 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2014

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2014

Asset Growth

100th percentile

22020%

Faster asset growth than 100% of similar nonprofits.

2014 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2013 to 2014

Revenue Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2013 to 2014

Assets

Up

$91,626,123

Up $91,211,906 (+22020%) from 2013

Net Assets

Up

$90,765,490

Up $90,765,621 (+69286734%) from 2013

Liabilities

Up

$860,633

Up $446,285 (+108%) from 2013

Revenue

Up

$94,632,976

Up $94,632,976 from 2013

Expenses

Up

$3,830,619

Up $3,830,488 (+2924037%) from 2013

Net Income

Up

$90,802,357

Up $90,802,488 (+69314876%) from 2013

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0-$50MAssets 2013: $414,217Liabilities 2013: $414,348Net Assets 2013: -$1312013Assets 2014: $91,626,123Liabilities 2014: $860,633Net Assets 2014: $90,765,4902014Assets 2015: $93,972,721Liabilities 2015: $1,191,474Net Assets 2015: $92,781,2472015Assets 2016: $95,139,687Liabilities 2016: $566,861Net Assets 2016: $94,572,8262016Assets 2017: $22,887,313Liabilities 2017: $517,970Net Assets 2017: $22,369,3432017Assets 2018: $23,560,103Liabilities 2018: $1,820,682Net Assets 2018: $21,739,4212018Assets 2019: $21,003,256Liabilities 2019: $1,150,029Net Assets 2019: $19,853,2272019Assets 2020: $20,006,242Liabilities 2020: $1,275,666Net Assets 2020: $18,730,5762020Assets 2021: $27,223,706Liabilities 2021: $914,946Net Assets 2021: $26,308,7602021Assets 2022: $16,430,730Liabilities 2022: $365,526Net Assets 2022: $16,065,2042022Assets 2023: $14,752,429Liabilities 2023: $165,446Net Assets 2023: $14,586,9832023Assets 2024: $13,627,794Liabilities 2024: $158,676Net Assets 2024: $13,469,1182024

Highlighted filing

2014

Assets$91,626,123
Liabilities$860,633
Net Assets$90,765,490

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100M$50M$0-$50M-$100MRevenue 2013: $0Expenses 2013: $131Net Income 2013: -$1312013Revenue 2014: $94,632,976Expenses 2014: $3,830,619Net Income 2014: $90,802,3572014Revenue 2015: $9,684,125Expenses 2015: $7,478,668Net Income 2015: $2,205,4572015Revenue 2016: $9,631,499Expenses 2016: $8,079,084Net Income 2016: $1,552,4152016Revenue 2017: $8,966,143Expenses 2017: $77,414,549Net Income 2017: -$68,448,4062017Revenue 2018: $5,963,159Expenses 2018: $6,568,585Net Income 2018: -$605,4262018Revenue 2019: $5,872,571Expenses 2019: $7,812,065Net Income 2019: -$1,939,4942019Revenue 2020: $5,787,769Expenses 2020: $6,938,014Net Income 2020: -$1,150,2452020Revenue 2021: $15,272,541Expenses 2021: $8,009,129Net Income 2021: $7,263,4122021Revenue 2022: $7,260,831Expenses 2022: $4,653,715Net Income 2022: $2,607,1162022Revenue 2023: -$3,532,420Expenses 2023: $1,387,565Net Income 2023: -$4,919,9852023Revenue 2024: $60,778Expenses 2024: $1,351,782Net Income 2024: -$1,291,0042024

Highlighted filing

2014

Revenue$94,632,976
Expenses$3,830,619
Net Income$90,802,357
Filing Detail Status

This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Oct 1, 2013 to Sep 30, 2014
Mission and Program Overview

Mission

Technology (art) clinics.providing broad access to single gene disorder diagnostics so that individual with a known genetic condition can have their embryos evaluated to improve their likelihood of having a baby who is not affected by the genetic conditionsponsoring research that advances the field of embryonic competence and provides a clear pathway to improved clinical outcomes and reduced complications for ivf pateints.supporting continuing medical education (cme), graduate-level educational initiatives, and other educational activities to advance our understanding and the application of embryonic diagnostics around the world.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings